biopharmaceutical company focused on the development of innovative immunotherapies for the treatment of tauopathies.
Business Model:
Revenue: $0
Employees: 1-10
Address: 5 New St Square,
City: London
State: england
Zip: EC4A 3TW
Country: GB
TAUC3BIO CORPORATION is a privately-held biopharmaceutical company focused on the development of innovative high precision immunotherapies for the treatment of tauopathies such as Alzheimer’s disease (AD) and Progressive Supranuclear Palsy (PSP). Its patented platform relates to the development of monoclonal antibodies (mAbs) targeting neurotoxic tau protein fragments, especially tauC3, with mAbs that do not bind to full-length tau (FLT). It was founded in 2019 and headquartered in Holborn, Camden.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2020 | Seed Round | 2 | - |
Alzheimer&s;s Association Rainwater Charitable Alzheimer&s;s Association Rainwater Charitable |
3/2020 | Seed Round | 2 | - |
Alzheimer&s;s Association Rainwater Charitable Alzheimer&s;s Association Rainwater Charitable |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|